A randomized trial comparing 5-mg and 10-mg warfarin loading doses.
about
Warfarin initiation nomograms for venous thromboembolismWarfarin initiation nomograms for venous thromboembolismOptimal loading dose of warfarin for the initiation of oral anticoagulationEvidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesOutpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesIntegration of genetic, clinical, and INR data to refine warfarin dosing.Optimal loading dose for the initiation of warfarin: a systematic reviewClinical utilization of the international normalized ratio (INR).Evaluation of warfarin initiation regimens in elderly inpatients.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Guidelines on oral anticoagulation (warfarin): third edition--2005 update.Anticoagulant-related skin reactions.Impact of Introducing Anticoagulation-Related Prescribing Guidelines in a Hospital Setting using Academic Detailing.Initiating warfarin therapy: 5 mg versus 10 mg.Genetic-based dosing in orthopedic patients beginning warfarin therapy.The pharmacogenetics of coumarin therapy.Factors influencing warfarin response in hospitalized patients.Effect of patient-specific factors on weekly warfarin doseStudy on Impact of Clinical Pharmacist's Interventions in the Optimal Use of Oral Anticoagulants in Stroke Patients.Vitamin K antagonist use in the elderly: special considerations.Patient factors that influence warfarin dose response.Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.Anticoagulants: A Review of the Pharmacology, Dosing, and Complications.Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery.Implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge.An evaluation of the early pharmacodynamic response after simultaneous initiation of warfarin and amiodarone.Warfarin dosage in postpartum women: a case-control study.Patient-specific factors predictive of warfarin dosage requirements.Assessment of an age-adjusted warfarin initiation protocol.Evaluation of a warfarin initiation protocol for older people.Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum.Unusual hypersensitivity to warfarin in a critically ill patient.Warfarin induction at 5 mg daily is safe with a low risk of anticoagulant overdose: results of an audit of patients with deep vein thrombosis commencing warfarin.Age- and weight-adjusted warfarin initiation nomogram for ischaemic stroke patients.Comparing Usual Care With a Warfarin Initiation Protocol After Mechanical Heart Valve Replacement.Gamma-glutamyl carboxylase and its influence on warfarin dose.Rationale and design of Triple AXEL: trial for early anticoagulation in acute ischemic stroke patients with nonvalvular atrial fibrillation.Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial.Warfarin dosing and body mass index.
P2860
Q24186324-5DC92B5B-9502-4245-B252-88390F3945BDQ24201274-7DEC48A0-2DDD-4979-87A4-555F82E633E2Q24202077-BA08F01F-C53E-43D2-A82E-B30CC9ABDAEAQ24632951-11E6E316-37D8-4785-8D7F-D232699E2D75Q33311569-B7FCBE29-6EE2-4E16-89B0-B2666776D9CEQ33399576-C5A34661-900F-4546-B08F-B9A59CED4C52Q33550741-C0B2A02B-BBF0-4454-AD09-FE9CC7C858D0Q33559159-C1BE70E1-9E6D-448B-85C7-942F049C24F7Q33910636-8ECEA9C0-A891-4AC7-B6F0-BDBFFA7547BBQ34000986-78ACA79C-0A47-48DB-B362-74899977C329Q34252907-852D8313-B542-4CC4-89EE-C7A408496932Q34484090-14A2D080-7AD9-456B-A5C1-922EC45FC741Q35194496-7C62C40A-5B20-4625-8EBA-3A58B81BC7BAQ35919133-7E32EB7C-90C0-4DD7-8352-0CE85A4BE8D7Q35937712-6E4C5FAF-D25E-4B00-B108-C27121A5A658Q35989429-8F6B615A-3119-4A62-95E3-DC759027238EQ36192806-CF1F5B91-54EC-46CD-BC06-74440D59F408Q36346124-3B5C895C-AD6E-4254-8BA7-EEE1ED3B5935Q36661285-2E6885A7-699E-4B46-A4C1-8F9358A5363DQ37034722-9CF7CC6C-EB3F-4766-9216-C902F75F952BQ37608565-503F5E9D-C6C9-4641-9DB8-71E301832468Q37867275-1033ED06-4C25-4E85-8A87-14124BC7E68BQ37933420-AFA698BB-ADAA-4D1A-BD38-7EA5E4DF28B8Q38107945-F54CC48C-B54C-4B12-9D0B-289828CE7CB4Q38786489-C20A4906-35D1-4A21-A756-1E5309C7D424Q39096124-73585F54-B899-4FCC-A8FB-26E01D88E8CFQ43191814-8FD881AC-2B7C-4D29-AC79-450AC091F70DQ43912454-5B10FCBD-5607-4295-BD69-BC2636FA82BAQ44146616-57E3F04F-4F5B-4D18-895B-71F28E8C6BBDQ44457483-C727A9A1-1E8B-4F85-9265-2FB06A0F418BQ44597362-259B4717-4533-4223-A609-C2F93D8CBD7CQ45052852-A0CEBAA3-5AAE-46CF-B145-0952CC1A696AQ45105259-731C30C9-1F4A-46A8-951D-2C1FB9418AB1Q46824385-B2D8B84A-D98F-42FD-9F13-800D84967065Q47305494-07BDF2D5-B4B8-4A24-A7DC-089E99E38E85Q48755205-D8558427-C072-4B15-89B8-B5F3A8298E1CQ49811574-7C633361-A003-4345-9DBD-BFA5D9242CEAQ51039938-2953100E-F0BF-4A19-91D1-55143125803AQ53089854-C6154E88-C6FB-47C9-A267-EF0BC7B4A466Q53094781-D1000276-31C1-4EE9-8319-B8C6FF0A9A15
P2860
A randomized trial comparing 5-mg and 10-mg warfarin loading doses.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
A randomized trial comparing 5-mg and 10-mg warfarin loading doses.
@en
A randomized trial comparing 5-mg and 10-mg warfarin loading doses.
@nl
type
label
A randomized trial comparing 5-mg and 10-mg warfarin loading doses.
@en
A randomized trial comparing 5-mg and 10-mg warfarin loading doses.
@nl
prefLabel
A randomized trial comparing 5-mg and 10-mg warfarin loading doses.
@en
A randomized trial comparing 5-mg and 10-mg warfarin loading doses.
@nl
P2093
P1476
A randomized trial comparing 5-mg and 10-mg warfarin loading doses.
@en
P2093
Crowther MA
Ginsberg JB
Harrison L
Massicotte MP
P356
10.1001/ARCHINTE.159.1.46
P407
P577
1999-01-01T00:00:00Z